Titans Unite: Medtronic, Philips Partner to Treat Lung Cancer

Two medtech titans are teaming up to market a software GPS solution to detect lung cancer. Medtronic and Royal Philips announced the partnership and unveiled the jointly developed LungGPS Patient Management Platform earlier this week. To date, lung cancer remains the No. 1 cancer killer in the world, accounting for more cancer deaths than breast, colon, and prostate cancer combined, according to statistics from the American Cancer Society. “From my perspective, I think both organizations realize that more needs to be done to help transform lung cancer from a death sentence or deadly diseases, to something that is more managed to give patients more time and a better quality of life,” Matt Anderson, vice president, general manager lung health for Medtronic’s surgical innovations business, told MD+DI. “I think we recognize that clinicians need better tools to help in that effort.” Hear Medtronic’s senior principal plastics engineer and principle metals engineer discuss making design manufacturable at the MD&M West Conference on February 7. Use promo code “MDDI” for 20% off registration. Medtronic and Philips said when lung nodules are found, the lack of infrastructure, coordination, and capacity to manage identified patients in a timely manner can lead to delays in diagnosis and treatment. Studies demonstrate the majority of patients with incidental nodule identification don't receive appropriate follow-up. They often go home either unaware of the issue or t...
Source: MDDI - Category: Medical Devices Authors: Tags: Business Source Type: news